ASHLEY HERNANDEZ: Open Payments
NPI 1700640018 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,097 in 169 payments from 14 companies in 2025. Trend: 2023 $97 · 2024 $2,781 · 2025 $3,097
Food & beverage: $3,097
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 60 | $955 |
| Takeda Pharmaceuticals U.S.A., Inc. | 30 | $511 |
| Janssen Biotech, Inc. | 22 | $415 |
| Madrigal Pharmaceuticals | 10 | $325 |
| Lilly USA, LLC | 19 | $314 |
| Celltrion USA Inc. | 8 | $157 |
| PFIZER INC. | 6 | $127 |
| Daiichi Sankyo Inc. | 3 | $79 |
| Organon LLC | 4 | $56 |
| Aimmune Therapeutics, Inc. | 2 | $42 |
Products named: ENTYVIO, RINVOQ, TREMFYA, REZDIFFRA, OMVOH, SKYRIZI, VEGZELMA, XELJANZ.
Industry payments across LA — which companies pay providers there.
